Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate
Authors:
- Ernesta Palombo-KinneEPErnesta Palombo-Kinne
- Ilka SchellschmidtISIlka Schellschmidt
- Ulrike SchumacherUSUlrike Schumacher
- Thomas GräserTGThomas Gräser
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 79 (4) , 282-289
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Treating acne with oral contraceptives: use of lower dosesContraception, 2006
- New progestagens for contraceptive useHuman Reproduction Update, 2005
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraceptionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2004
- Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programmeBritish Journal of Dermatology, 2004
- Effect of dienogest-containing oral contraceptives on lipid metabolismContraception, 2002
- THE EFFECTS OF VALETTE® ON SKIN AND HAIR: A POST‐MARKETING SURVEILLANCE STUDYInternational Journal Of Clinical Practice, 2000
- Acne VulgarisArchives of Dermatology, 1999
- Oral Contraceptives and Cyproterone Acetate in Female Acne TreatmentDermatology, 1998
- Report of the consensus conference on acne classificationJournal of the American Academy of Dermatology, 1991